Carnecchia, Baldo M.; Kurtzke, John F.
November 1960
Annals of Internal Medicine;Nov60, Vol. 53 Issue 5, p1027
Academic Journal
Studies fatal toxic reaction to amphotericin B in cryptococcal meningo-encephalitis. Case report of a 32-year-old worker with a progressive paraparesis; Description of cryptococcus neoformans; Details about the administration of amphotericin B.


Related Articles

  • Cryptococcal Meningoencephalitis. Martin, R.A.; Bates, D.; Shaw, D.A. // British Medical Journal;7/12/1975, Vol. 3 Issue 5975, p75 

    Examines the effect of amphotericin B on the treatment of cryptococcal meningoencephalitis. Accumulation of cryptococcal antigens; Association of meningitis with psychiatric disturbance; Periods of disorientation and aggression.

  • Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal. Loyse, Angela; Dromer, Françoise; Day, Jeremy; Lortholary, Olivier; Harrison, Thomas S. // Journal of Antimicrobial Chemotherapy (JAC);Nov2013, Vol. 68 Issue 11, p2435 

    Current, widely accepted guidelines for the management of HIV-associated cryptococcal meningoencephalitis (CM) recommend amphotericin B combined with flucytosine (5-FC) for ≥2 weeks as the initial induction treatment of choice. However, access to flucytosine in Africa and Asia, where...

  • A rare case of survival from primary amebic meningoencephalitis. Gautam, Parshotam Lal; Sharma, Shruti; Puri, Sandeep; Kumar, Raj; Midha, Vandana; Bansal, Rajinder // Indian Journal of Critical Care Medicine;Jan-Mar2012, Vol. 16 Issue 1, p34 

    Primary amebic meningoencephalitis (PAM) is a rare and fatal disease of central nervous system (CNS) caused by Naegleria fowleri, an ameba found in soils and warm waters. It enters the CNS after insufflation of infected water by attaching itself to the olfactory nerves. The infection is usually...

  • Antifolates inhibit Cryptococcus biofilms and enhance susceptibility of planktonic cells to amphotericin B. Aguiar Cordeiro, R.; Mourão, C.; Rocha, M.; Farias Marques, F.; Teixeira, C.; Oliveira Miranda, D.; Neto, L.; Brilhante, R.; Jesus Pinheiro Gomes Bandeira, T.; Sidrim, J. // European Journal of Clinical Microbiology & Infectious Diseases;Apr2013, Vol. 32 Issue 4, p557 

    The Cryptococcus neoformans species complex contains the most important agents of fungal meningoencephalitis. Therapeutic choices are limited and issues related to toxicity and resistance to antifungals have been described. The present study evaluated the inhibitory effect of the antifolate...

  • Emergence of Amphotericin B-Resistant Cryptococcus laurentii Meningoencephalitis Shortly After Treatment for Cryptococcus neoformans Meningitis in a Patient with AIDS. Manfredi, Roberto; Fulgaro, Ciro; Sabbatani, Sergio; Legnani, Giorgio; Fasulo, Gianni // AIDS Patient Care & STDs;Apr2006, Vol. 20 Issue 4, p227 

    A unique occurrence of two subsequent episodes of HIV-associated Cryptococcus neoformansfollowed by C. laurentii meningoencephalitis (successfully cured with fluconazole after demonstrated amphotericin B resistance) is presented and discussed. The available literature reported only two cases of...

  • Comparative Efficacy and Distribution of Lipid Formulations of Amphotericin... Groll, Andreas H.; Giri, Neelam; Petraitis, Vidmantas; Petraitiene, Ruta; Candelario, Myrna; Bacher, John S.; Piscitelli, Stephen C.; Walsh, Thomas J. // Journal of Infectious Diseases;7/1/2000, Vol. 182 Issue 1, p274 

    Examines the central nervous system distribution and antifungal efficacy of four approved formulations of amphotericin B (AmB) in a rabbit model of hematogenous Candida albicans meningoencephalitis. Concentrations of AmB cerebrospinal fluid and brain tissue; Pharmacokinetic and pharmacodynamic...

  • EXPERIENCE OF PRIMARY AMOEBIC MENINGOENCEPHALITIS IN ICU, PNS SHIFA, KARACHI. Asghar, Syed Parvez; Ather, Nadia; Farooque, Mohammad; Sidra; Asghar, Sarah; Tahir, Mohammad // Pakistan Armed Forces Medical Journal;9/30/2014, Vol. 64 Issue 3, p505 

    The article presents a case study of six male patients with primary amoebic meningoencephalitis (PAM) caused by Naegleria fowleri in intensive care unit (ICU) in Karachi, Pakistan. Clinical examination of five patients showed confusion, disorientation and irritability, while one of the patients...

  • Pharmacodynamics of Liposomal Amphotericin B and Flucytosine for Cryptococcal Meningoencephalitis: Safe and Effective Regimens for Immunocompromised Patients. O'Connor, Lucy; Livermore, Joanne; Sharp, Andrew D.; Goodwin, Joanne; Gregson, Lea; Howard, Susan J.; Felton, Timothy W.; Schwartz, Julie A.; Neely, Michael N.; Harrison, Thomas S.; Perfect, John R.; Hope, William W. // Journal of Infectious Diseases;Jul2013, Vol. 208 Issue 2, p351 

    Background. Cryptococcal meningoencephalitis is a lethal infection with relatively few therapeutic options. The optimal dosage of liposomal amphotericin B (LAmB) alone or in combination with flucytosine is not known.Methods. A murine model of cryptococcal meningoencephalitis was used. The fungal...

  • In vitro Susceptibility of Naegleria fowleri Trophozoites to Amphotericin B-combined Chlorpromazine. Tiewcharoen, S.; Rabablert, J.; Junnu, V. // Research Journal of Microbiology;2009, Vol. 4 Issue 9, p320 

    The objective of this study was to study the susceptibility of Naegleria fowleri trophozoites to Amphotericin B-combined chlorpromazine investigated the activities of single drugs used in combination with amphotericin B compared to those of each drug alone in vitro. The 50% inhibitory...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics